Posted on 11/05/2021 2:06:42 AM PDT by markomalley
A powerful rally in the shares of companies that produced breakthrough vaccines to provide protection against the deadly coronavirus is showing signs of peaking.
Moderna (NASDAQ:MRNA) shares closed down almost 18% yesterday after the company’s sales and earnings missed analysts’ target by a big margin. The Massachusetts-based Moderna told investors its vaccine sales would be between $15 billion and $18 billion in 2021. Previously, the company had said it had signed agreements for $20 billion in anticipated 2021 vaccine sales.
In a statement, Moderna said longer lead times for international orders may shift some deliveries into 2022. The company cited a “temporary impact” as it attempts to expand its capacity to fill and finish vaccine vials.
Moderna stock, which closed yesterday at $284.02, has lost a quarter of its value during the past three months and more than 40% since reaching a record high in August. Pfizer (NYSE:PFE), another global vaccine giant, has hardly budged during the past three months.
(snip)
Bottom Line
We believe the best days to make money on vaccine stocks are behind us. More vaccine supplies, from the low-cost producers like India to the authorization of antiviral pills like the one Merck has developed, will continue to weigh on the sales of western vaccine producers, including Moderna and Pfizer.
(Excerpt) Read more at investing.com ...
Yesterday they were playing radio ads from multiple entities sometimes back to back all day to get the vax. There was even an offer of one hundred dollars to get it. Amazing.
When you start hearing stories on alternative media about kids between 5-11 having heart attacks, that’s when it’s time to sell. A 20, 30, 40 year old having a heart attack is a coincidence. An 8 year old dying of a heart attack is going to inspire a lot of very pissed off parents to act in a manner that is likely not predictable.
Some are ‘improved’ like novavax. Some companies do more than vaccines. I would look at each stock on its own merit.
As part of the “warp speed” effort, do these vax manufacturers have blanket immunity from liability for the damage they’re causing?
I’m not positive after approval, but immunity when you take it as an experimental vaccine. I would read ‘right to try’ legislation. We may see companies pull out of vaccines once they are no longer experimental or shortly thereafter. I don’t hold any moderna, so I am not aware of their status other than some concerning side effects.
Isn’t Pfizer the only vacc approved to give 5-11 yo test rats (children)?
If so, that’s got to contribute to Moderna’s slide in share price.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.